Skip to Content

Biotika AS 1BSL01AE

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

1BSL01AE is trading within a range we consider fairly valued.
Price
€24.18
Fair Value
€42.43
Uncertainty
Extreme
1-Star Price
€355.74
5-Star Price
€8.17
Economic Moat
Tyrmx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 1BSL01AE is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
205

Valuation

Metric
1BSL01AE
Price/Earnings (Normalized)
Price/Book Value
0.62
Price/Sales
Price/Cash Flow
Price/Earnings
1BSL01AE

Financial Strength

Metric
1BSL01AE
Quick Ratio
2.02
Current Ratio
3.91
Interest Coverage
Quick Ratio
1BSL01AE

Profitability

Metric
1BSL01AE
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
1BSL01AE
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRSvdpbzrlqGrxkyw$69.8 Bil
ZTS
Zoetis Inc Class AHdymwztwKmjw$68.9 Bil
HLN
Haleon PLC ADRNzkqhmskTjrw$37.7 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRDhwdwdkGrdt$14.8 Bil
VTRS
Viatris IncSnmvpqxvZkcw$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRCqgxmfwmlXjlq$11.9 Bil
CTLT
Catalent IncFnnssvvjVtvmt$10.1 Bil
PRGO
Perrigo Co PLCXwhbbrqXwr$4.2 Bil
CURLF
Curaleaf Holdings IncTtlbqlxqFsg$3.6 Bil
PBH
Prestige Consumer Healthcare IncCwcmspcxWpvjlsf$3.5 Bil

Sponsor Center